Oramed to Present at the Rodman & Renshaw Global Investment Conference
JERUSALEM, August 29, 2017 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ/TASE: ORMP) (https://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming Rodman & Renshaw 19th Annual Global Investment Conference, taking place on September 10-12, 2017 in New York City. Nadav Kidron, Oramed’s […]
